Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab

BACKGROUND: Indication of omalizumab in the United States was recently extended to include pediatric (6–11 years) uncontrolled moderate-to-severe allergic asthma patients. OBJECTIVE: The purpose of this study was to describe baseline characteristics of this population from a real-world dataset. METH...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Allergy Rhinol (Providence)
Hlavní autoři: Kavati, Abhishek, Pilon, Dominic, Ortiz, Benjamin, Paknis, Brandee, Vegesna, Ashok, Schiffman, Bradd, Zhdanava, Maryia, Lefebvre, Patrick, Stone, Brian
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028162/
https://ncbi.nlm.nih.gov/pubmed/29977648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2152656718763387
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky